Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
University of Virginia
Istari Oncology, Inc.
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
National Cancer Institute (NCI)
City of Hope Medical Center
Bristol-Myers Squibb
Wake Forest University Health Sciences
Barbara Ann Karmanos Cancer Institute
Stanford University
Novartis
Memorial Sloan Kettering Cancer Center
University of South Florida
INSYS Therapeutics Inc
Eli Lilly and Company